Merkliste 
 1 Ergebnisse 
 
1

Cost-effectiveness analysis of serplulimab plus chemotherap..:

Shixian Liu ; Nana Jiang ; Lei Dou.
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1172242/full.  , 2023